The new bedside ROCky score to predict the complications in patients with intermediate-risk pulmonary embolism


      • The new score to predict complications in intermediate-high risk PE is proposed.
      • ROCKy Score includes positive hFABP, HR ≥ 110 bpm, SBP ≤ 100 mmHg and presence of DM.
      • The most important PE complication that has to be predicted is obstructive shock.
      • ROCKy Score could be a perspective tool in further studies.



      Pulmonary embolism (PE) remains one of the leading causes of mortality among cardiovascular diseases. We aimed at investigating risk factors of PE complications in patients with intermediate risk and integrate them into a simple model for its' bedside prediction.


      Among 173 patients with PE, 136 were classified as high or intermediate risk. Patients were retrospectively divided into groups of complicated (n = 44) or uncomplicated (n = 92) course. Study endpoints: obstructive shock, recurrent PE, needs for resuscitation/thrombolysis/hemodynamic support and death during 30 days.


      Predictors of PE complications were: chronic heart failure, diabetes mellitus (DM), atrial fibrillation, permanent risk factor of venous thromboembolism, syncope, positive heart-type fatty acid binding protein (hFABP), positive troponin I, heart rate (HR) ≥ 110 bpm, systolic blood pressure (SBP) ≤ 100 mmHg, creatinine clearance ≤ 70 ml/min. Multivariate logistic regression analysis was used to model a simple predictive score named ROCky (Risk of Complications): HR ≥ 110 bpm (1.5 points), SBP ≤ 100 mmHg (2.5 points), positive hFABP (2 points) and presence of DM (2.5 points). The AUROC of this model was 0.89 to predict any complication, 0.83 for obstructive shock and 0.92 for death from any cause; the optimal cut-off scores for any complication was ≥2.5 points, ≥3.5 for obstructive shock and ≥4.5 points for death within 30 days.


      hFABP, tachycardia, hypotension and DM were identified as the major independent determinants of complications development in patients with pulmonary embolism and may be used in combination as the bedside simple predictive ROCky score for early risk stratification in intermediate-risk group.



      BNP (brain natriuretic peptide), ESC (European Society of Cardiology)
      To read this article in full you will need to make a payment

      Purchase one-time access:

      Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online access
      One-time access price info
      • For academic or personal research use, select 'Academic and Personal'
      • For corporate R&D use, select 'Corporate R&D Professionals'


      Subscribe to European Journal of Internal Medicine
      Already a print subscriber? Claim online access
      Already an online subscriber? Sign in
      Institutional Access: Sign in to ScienceDirect


        • Heit J.A.
        The epidemiology of venous thromboembolism in the community.
        Arterioscler Thromb Vasc Biol. 2008; 28: 370-372
        • Konstantinides S.V.
        • Torbicki A.
        • Agnelli G.
        • et al.
        2014 ESC guidelines on the diagnosis and management of acute pulmonary embolism.
        Eur Heart J. 2014; 35: 3033-3080
        • Lankeit M.
        • Jimenez D.
        • Kostrubiec M.
        • et al.
        Predictive value of the high-sensitivity troponin T assay and the simplified pulmonary embolism severity index in hemodynamically stable patients with acute pulmonary embolism: A prospective validation study.
        Circulation. 2011; 124: 2716-2724
        • Elias А.
        • Mallett S.
        • Daoud-Elias M.
        • et al.
        Prognostic models in acute pulmonary embolism: A systematic review and meta-analysis.
        BMJ Open. 2016; 6e010324
        • Jiménez D.
        • Lobo J.L.
        • Barrios D.
        • et al.
        Risk stratification of patients with acute symptomatic pulmonary embolism.
        Intern Emerg Med. 2016; 11: 11-18
        • Becattini C.
        • Vedovati M.C.
        • Agnelli G.
        Prognostic value of troponins in acute pulmonary embolism: A meta-analysis.
        Circulation. 2007; 116: 427-433
        • Jiménez D.
        • Uresandi F.
        • Otero R.
        • et al.
        Troponin-based risk stratification of patients with acute nonmassive pulmonary embolism: Systematic review and meta-analysis.
        Chest. 2009; 136: 974-982
        • Bajaj A.
        • Rathor P.
        • Sehgal V.
        • et al.
        Risk stratification in acute pulmonary embolism with heart-type fatty acid-binding protein: A meta-analysis.
        J Crit Care. 2015; 30: 1151.e1-1151.e7
        • Coutance G.
        • Le Page O.
        • Lo T.
        • et al.
        Prognostic value of brain natriuretic peptide in acute pulmonary embolism.
        Crit Care. 2008; 12: 109
        • Bajaj A.
        • Rathor P.
        • Sehgal V.
        • et al.
        Prognostic value of biomarkers in acute non-massive pulmonary embolism: A systematic review and meta-analysis.
        Lung. 2015; 193: 639-651
        • Liu M.
        • Yuan X.
        • Qiu X.
        • et al.
        Prognostic role of heart-type fatty acid binding protein in pulmonary embolism: A meta-analysis.
        Thromb Res. 2015; 135: 20-25
        • Lankeit M.
        • Dellas C.
        • Benz V.
        • et al.
        The predictive value of heart-type fatty acid-binding protein is independent from symptom duration in normotensive patients with pulmonary embolism.
        Thromb Res. 2013; 132: 543-547